BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 11372182)

  • 1. [Frey syndrome after lateral parotidectomy. Follow-up and therapeutic outlook].
    Küttner C; Berens A; Tröger M; Keil C; Eckardt A
    Mund Kiefer Gesichtschir; 2001 Mar; 5(2):144-9. PubMed ID: 11372182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin for treatment of gustatory sweating. A prospective randomized study].
    Nolte D; Gollmitzer I; Loeffelbein DJ; Hölzle F; Wolff KD
    Mund Kiefer Gesichtschir; 2004 Nov; 8(6):369-75. PubMed ID: 15517441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A.
    Eckardt A; Kuettner C
    Head Neck; 2003 Aug; 25(8):624-8. PubMed ID: 12884344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of incidence of Frey's syndrome diagnosed based on clinical signs and Minor's test after parotis surgery.
    Tuncel A; Karaman M; Sheidaei S; Tatlıpınar A; Esen E
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(4):200-6. PubMed ID: 22770254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of botulinum toxin A in the treatment of gustatory sweating].
    Küttner C; Tröger M; Dempf R; Eckardt A
    Nervenarzt; 2001 Oct; 72(10):787-90. PubMed ID: 11688180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome).
    Laskawi R; Drobik C; Schönebeck C
    Laryngoscope; 1998 Mar; 108(3):381-4. PubMed ID: 9504611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A for Frey's syndrome: a preliminary prospective study.
    Laccourreye O; Muscatelo L; Naude C; Bonan B; Brasnu D
    Ann Otol Rhinol Laryngol; 1998 Jan; 107(1):52-5. PubMed ID: 9439389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of medical thermography in treatment of Frey's syndrome with botulinum toxin A.
    Green RJ; Endersby S; Allen J; Adams J
    Br J Oral Maxillofac Surg; 2014 Jan; 52(1):90-2. PubMed ID: 24238875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frey's syndrome: treatment with botulinum toxin.
    Bjerkhoel A; Trobbe O
    J Laryngol Otol; 1997 Sep; 111(9):839-44. PubMed ID: 9373550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Post-parotidectomy Frey's syndrome. Treatment with botulinum toxin type A].
    Cavalot AL; Palonta F; Preti G; Nazionale G; Ricci E; Staffieri A; Di Girolamo S; Cortesina G
    Acta Otorhinolaryngol Ital; 2000 Jun; 20(3):187-91. PubMed ID: 11139877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between skin flap thickness and Frey's syndrome in parotid surgery.
    Durgut O; Basut O; Demir UL; Ozmen OA; Kasapoglu F; Coskun H
    Head Neck; 2013 Dec; 35(12):1781-6. PubMed ID: 23471856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe Frey syndrome after parotidectomy: treatment with botulinum neurotoxin type A].
    Laccourreye O; Muscatello L; Gutierrez-Fonseca R; Seckin S; Brasnu D; Bonan B
    Ann Otolaryngol Chir Cervicofac; 1999 Jun; 116(3):137-42. PubMed ID: 10399528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frey's syndrome--unusually long delayed clinical onset post-parotidectomy: a case report.
    Chamisa I
    Pan Afr Med J; 2010 Apr; 5():1. PubMed ID: 21120000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of acellular dermis in the prevention of Frey's syndrome.
    Govindaraj S; Cohen M; Genden EM; Costantino PD; Urken ML
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1993-8. PubMed ID: 11801985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unusually long latency before the appearance of Frey's syndrome after parotidectomy].
    Wenzel GI; Draf W
    HNO; 2004 Jun; 52(6):554-6. PubMed ID: 15257402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gustatory sweating following parotidectomy. Frey's syndrome].
    Hüttenbrink KB; Hüttenbrink B
    Laryngol Rhinol Otol (Stuttg); 1986 Mar; 65(3):130-4. PubMed ID: 3713389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of botulinum toxin in Frey's Syndrome.
    Khoo SG; Keogh IJ; Timon C
    Ir Med J; 2006 May; 99(5):136-7. PubMed ID: 16892916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of irradiate animal pericardium membrane for prevention of Frey's syndrome after parotidectomy.
    Gennaro P; Di Curzio P; Mitro V; Facchini A; Saponaro G; Cascino F; Amodeo G; Gabriele G; Ungari C
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):548-51. PubMed ID: 23467957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of allogenic acellular dermal matrix in prevention of Frey's syndrome after parotidectomy.
    Ye WM; Zhu HG; Zheng JW; Wang XD; Zhao W; Zhong LP; Zhang ZY
    Br J Oral Maxillofac Surg; 2008 Dec; 46(8):649-52. PubMed ID: 18547692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of Frey syndrome with botulinum toxin A. Experiences with a new method of treatment].
    Drobik C; Laskawi R; Schwab S
    HNO; 1995 Nov; 43(11):644-8. PubMed ID: 8530311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.